#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stress cardiomyopathy Meningitis meningococcal Ewing's sarcoma metastatic Hepatoblastoma Neuropathic arthropathy Hereditary hypophosphataemic rickets Advanced systemic mastocytosis Haemophilia A without inhibitors Pouchitis Microscopic polyangiitis Haemophilia B without inhibitors Allogenic stem cell transplantation Systemic candida Haemophilia B with anti factor IX Infective uveitis More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Diagnostics X-linked lymphoproliferative syndrome – Diagnostics Basal cell naevus syndrome – Diagnostics Wiskott-Aldrich syndrome – Life with Disease Fragile X syndrome – Diagnostics Langerhans cell sarcoma – Trials in Disease Leiomyosarcoma – Life with Disease Phenylketonuria – Diagnostics Nephrotic syndrome – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VMX-C001 Mepacrine SEVUPARIN BENZYDAMINE HYDROCHLORIDE D5-Ethyl-Beta-D-Glucuronide Oteracil Abc-23A-116 ABBV-8736 Oric-114 Bidridistrogene Xeboparvovec Selinexor Sodium Phosphate Tolebrutinib Mb-Cart20.1 Inavolisib Varegacestat Olmesartan Medoxomil Fostemsavir Trometamol Co-Trimoxazole VERTEPORFIN More therapies…

    Learn about Your Condition

    Hepatitis D Actinic cheilitis Lung neoplasm malignant Breast cancer Dysmenorrhoea Chordoma Pulmonary resection Anaemia of chronic disease Spinal osteoarthritis Oesophageal disorder Brain abscess Deafness neurosensory Anal squamous cell carcinoma Mite allergy External cephalic version More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Salivary gland cancer

  • Safety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Dexamethasone Acetate
    • Epinephrine
    France

  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zanidatamab
    Spain

  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Malignant neoplasm of ampulla of Vater
    • Salivary gland cancer
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Denmark France Italy Spain

  • Study on Sentinel Lymph Node Biopsy for Parotid Gland Cancer Using Gallium (68Ga) Chloride and Tilmanocept in Patients Undergoing Parotidectomy and Neck Dissection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Tilmanocept
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study on the Effectiveness of Dutasteride with Goserelin Acetate and Bicalutamide in Patients with Recurrent or Metastatic Salivary Duct Carcinoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Dutasteride
    • Bicalutamide
    • Goserelin Acetate
    The Netherlands

  • Study of Capecitabine for Patients with Recurrent or Metastatic Salivary Duct Carcinoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Capecitabine
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!